Adjusted Earnings: $1.3 billion or $1.96 per share, up 7% from the same period a year ago. Adjusted Return on Equity: 14.4% for the first quarter. Direct Expense Ratio: 12% for the first quarter. Group Benefits Adjusted Earnings: $367 million, up 29% from the prior year period. Retirement and Income Solutions Adjusted Earnings: $401 million in the quarter. Asia Adjusted Earnings: $374 million, down 12% from the same period a year ago. Latin America Adjusted Earnings: $218 million, down 6% from the year-ago period. Capital Returned to Shareholders: $1.8 billion through common stock dividends and share repurchases. New Share Repurchase Authorization: $3 billion, with total board authorization at $3.4 billion. Cash and Liquid Assets: $4.5 billion at holding companies, above the target cash buffer of $3 billion to $4 billion. US Statutory Adjusted Capital: Approximately $16.4 billion as of March 31, 2025. Japan Solvency Margin Ratio: Expected to be approximately 725% as of March 31. Warning! GuruFocus has detected 7 Warning Signs with INN. Release Date: May 01, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points MetLife Inc (NYSE:MET) reported adjusted earnings of $1.3 billion or $1.96 per share, up 7% from the same period a year ago. The company saw favorable underwriting, good volume growth, and better variable investment income in the quarter. MetLife Inc (NYSE:MET) announced a significant risk transfer deal with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of US retail variable annuity and rider reserves. The company returned around $1.8 billion to shareholders through common stock dividends and share repurchases in the first quarter. MetLife Inc (NYSE:MET) has been named among the 100 best companies to work for by Fortune for the third year in a row. Negative Points Adjusted earnings in Asia were down 12% over the same period a year ago due to lower underwriting margins and higher taxes. Latin America adjusted earnings were down 6% from the year-ago period, impacted by foreign exchange rates. The company experienced a decline in spreads in the RIS business due to lower rates and a flatter curve than expected. MetLife Holdings adjusted earnings were down 3% due to the runoff of the business. The company faced challenges in the current environment, making it difficult to predict private equity returns. Q & A Highlights Q: Can you explain the decline in spreads in the Retirement and Income Solutions (RIS) business and whether this trend will continue? A: John McCallion, Executive Vice President and CFO, explained that the decline in spreads was due to the roll-off of interest rate caps and unexpected paydowns in higher-yielding structured securities. Despite these challenges, growth in liability balances exceeded expectations, and spreads are expected to stabilize in the second quarter. Story Continues Q: How is the current economic environment affecting MetLife's capital management and expense strategy? A: Michel Khalaf, President and CEO, stated that while the possibility of a recession has increased, MetLife's strategy remains unchanged. The company continues to focus on executing its strategic pillars and managing discretionary expenses, while maintaining confidence in its financial standing and capital management actions. Q: Can you provide details on the risk transfer deal with Talcott Resolution Life Insurance Company? A: Ramy Tadros, Regional President, U.S. Business, explained that the deal involves reinsuring approximately $10 billion of US retail variable annuity and rider reserves. This transaction aligns with MetLife's strategy to reduce tail risk and capital requirements, while the economic value received was in line with expectations. Q: What is the outlook for MetLife's group benefits business, particularly in terms of premium growth? A: Ramy Tadros noted that the reported 2% growth was impacted by favorable mortality in participating contracts and dental rate actions. Excluding these factors, underlying growth was about 4%. The company expects full-year growth to align with its 4% to 7% guidance, with no change to the earnings outlook. Q: How is MetLife's Asia business performing, and what are the expectations for sales growth? A: Lyndon Oliver, Regional President, Asia, reported a strong start to the year with a 10% increase in sales across the region. Japan showed sequential growth, and a new product launch in the bank channel is expected to sustain momentum. Sales in other Asian markets, particularly China and Korea, were also robust. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
MetLife Inc (MET) Q1 2025 Earnings Call Highlights: Strong Earnings Growth Amid Regional Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...